Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy
NANJING, China, Aug. 21, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has...
Korea's Startups Poised for a Landmark Season as COMEUP 2025 and CES 2026 Draw Near
SEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ -- Korea is preparing for a defining season in global innovation, as Seoul readies for COMEUP 2025—hosted by the Ministry of SMEs and Startups—and Korean entrepreneurs mark final preparations for their...
ARTERY Drives Exoskeleton Innovation with AT32 MCU for Smart Medical Applications
TAIPEI, June 25, 2025 /PRNewswire/ -- In recent years, exoskeleton robots have gained traction in various countries, including Japan, Germany, and the United States, where they are being explored for use in tourism and outdoor mobility support....